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Abstract
Introduction: Obesity and associated metabolic disorders are a worldwide
epidemic. Recent evidence suggests that the microbial community in the human
intestine may play an important role in the pathogenesis of obesity. The aim of
this study was to assess the differences in the composition of the intestinal
microbiota between obese and normal weight Egyptian children and adults.
Material and methods: The study included 79 subjects among whom 51 were
obese (23 children and 28 adults), and 28 were subjects of normal weight 
(17 children and 11 adults). Faecal samples were collected from all subjects. Total
DNA was extracted from collected stool samples and submitted to conventional
PCR for detection of Firmicutes and Bacteroidetes. All the studied group was
subjected to clinical and anthropometric evaluation. Laboratory assessment of
fasting glucose, high-sensitivity C-reactive protein (hsCRP) and lipid profile was
performed.
Results: The proportions of the phyla Firmicutes and Bacteroidetes were
statistically significantly increased in the obese group compared to the normal
weight group (p < 0.001, p = 0.003 respectively). The study also found
a statistically significant positive trend for higher hsCRP in subjects with positive
Firmicutes (p = 0.004). However, no associations were found between positive
Bacteroidetes and hsCRP .
Conclusions: The results of this study indicate that obesity in Egyptian children
and adults is associated with compositional changes in faecal microbiota with
increase in the phyla Firmicutes and Bacteroidetes. This could be considered
when developing strategies to control obesity and its associated diseases by
modifying the gut microbiota.
Key words: obesity, gut microbiota, Firmicutes, Bacteroidetes, high-sensitivity 
C-reactive protein.
Introduction 
Obesity represents one of the five major health risks in modern societies
with a frequency of more than 20% of the population in developed
countries [1]. As a consequence of the expected dramatic increase in
obesity prevalence rates, life expectancy may start to decrease for the first
time in recent history due to numerous co-morbid disorders [2, 3].
The intestinal flora has been recently proposed as an environmental
factor involved in the control of body weight and energy homeostasis 
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Copyright © 2011 Termedia & Banach[4-8]. The human intestine contains a large variety
of microorganisms, consisting of at least 1014
bacterial cells and up to 500-1000 different species
[9]. As a whole this represents overall more than
100 times the human genome [9, 10], and is called
the “metagenome”. Thus, the intestinal flora can
be considered as an “exteriorized organ” which
contributes to our homeostasis with multiple, highly
diversified functions. Studies have shown that the
gut microbiota is dominated by 2 bacterial phyla,
the gram-negative Bacteroidetes and the gram-
positive, low GC% Firmicutes [11, 12], with other
phyla represented at subdominant levels including
the Actinobacteria, Fusobacteria and Verruco  -
microbia phyla [11]. Within these phyla the domi  -
nant bacterial groups include the Clostridium
coccoides-Eubacterium rectale group, Clostridium
leptum group (Firmicutes), Bacteroides-Prevotella
species (Bacteroidetes), Bifidobacterium  and
Atopobium  genera (both Actinobacteria) [13].
Firmicutes are in the class Bacillus [14], which is rare
in the human or mouse gut microbiota; none is
a member of the Clostridium XIV class, which
contains the most abundant representatives of this
division in the distal guts of mice and humans.
Hence, the physiological contributions of Firmicutes
to the intestinal ecosystem, and to fuel partitioning,
are unclear [14].
Diet-induced and genetically obese mice (ob/ob
or db/db) showed a significant upregulation of
expression of Toll-like receptors 1 to 9 in adipocytes
and pre-adipocytes along with higher cytokine
production upon stimulation [15]. In particular, it is
known that Toll-like receptor 4 (TLR-4) can be
activated by both lipopolysaccharide (LPS) and
dietary saturated fatty acids inducing upregulation
of common intracellular inflammatory pathways,
such as JNK and NF-κB in adipocytes and macro  -
phages, related to the induction of insulin
resistance and increased adiposity [16]. Recently,
metabolic endotoxaemia, characterized by an
increase in serum LPS levels, has been demon  -
strated to be an inflammatory factor, causing body
weight gain, insulin resistance, and diabetes in
high-fat fed animal models [17-19].
C-reactive protein (CRP) is an acute-phase
protein that is a sensitive marker for systemic
inflammation. Several inflammation-related
diseases such as respiratory disease, rheumatoid
arthritis, diabetes mellitus, and cardiovascular
disease have been associated with elevated CRP
concentrations. Moreover, recent studies have
reported a positive relation between body mass
index and CRP concentrations [20-22]. In obesity,
an elevated CRP level concentration is explained by
increased interleukin-6 expression in adipose tissue
and its release into the peripheral circulation. The
role of the gut microbiota in modulating plasma LPS
levels, which triggers the inflammatory tone and
the onset of obesity and type 2 diabetes, is under
evaluation [23]. More studies are needed to unravel
how changing gut microbiota impacts on the
development of obesity and related metabolic
alterations. The idea that gut microbial diversity is
linked to obesity deserves exploration in humans,
because it may yield new treatment strategies for
this growing worldwide threat to our health.
The aim of this study was to assess the
differences in the composition of the intestinal
microbiota between obese and normal weight
Egyptian children and adults by comparing the
Firmicutes and Bacteroidetes frequency in the stool
and its correlation with high-sensitivity C-reactive
protein (hsCRP), as a marker of inflammation, and
also the correlation with the amount of dietary fat
and carbohydrate intake. 
Material and methods
All subjects were recruited between September
2008 and December 2009 from outpatient clinics
at the National Research Centre (NRC). Out of 120
subjects randomly chosen, only 79 were included
in this study, among whom 51 were obese (23
children and 28 adults), and 28 were subjects of
normal weight (17 children and 11 adults). Cases
with hepatic disease, hypertension, asthma,
infection, tumour, febrile conditions (or had febrile
conditions within the previous 2 months),
congestive heart failure, diseases affecting the gut
microbiota, recent antibiotic intake and other acute
inflammatory diseases were excluded from this
study. Obesity in children and adults was consi  -
dered as body mass index (BMI) ≥ 30 kg/m2 and
overweight as BMI ≥ 25 kg/m2 and < 30 kg/m2 [24].
Corresponding normative data for Egyptian children
and adolescents were used. Overweight was
defined as between the 90th and 95th BMI
percentiles and obesity as > 95th percentile in both
children and adolescents.
A detailed medical and family history was
obtained from all subjects and a complete physical
examination was performed, including anthro  po  -
metric parameters (height, weight), fatness indices
(BMI, standard deviation score-BMI – SDS-BMI, and
basal blood pressure). 
Nutritional evaluation
Twenty-four-hour dietary recalls for three
successive days were done for all cases and were
evaluated according to the food pyramid guidelines.
Food frequency questionnaires (FFQs) ask about the
usual frequency of consumption of a list of foods
mainly to evaluate fat and carbohydrate intake.
Stool samples were collected from all subjects
and were diluted as 20% using sterile EDTA (50 mM),
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then all samples were purified from stool deprise by
centrifugation at 5000 rpm for 10 min [25].
DNA extraction
DNA was extracted from diluted stool samples
using Wizard Genomic DNA Purification Kit
(Promega, Cat. No. A1120), according to the
manufacturer’s instructions, and extracted DNA was
stored at –20°C for detection of Bacteroidetes and
Firmicutes by PCR [25, 26].
Polymerase chain reaction
Oligonucleotide primers
For amplification of selected DNA segments of
Bacteroidetes and Firmicutes, two pairs of
oligonucleotide primers were used as detected in
stool samples using primers reported by Dick and
Field, 2004 and Scupham et al., 2006, respectively
[25, 27]. The primer sequences were: BactFA
ACGCTAGCTACAGGCTTAACA (Forward) and BactR
ACGCTACTTGGCTGGTTCA (Reverse), for Bactero  -
idetes, and FirmF GCGTGAGTGAAGAAGT (Forward)
and FirmR CTACGCTCCCTTTACAC (Reverse) for
Firmicutes.
PCR amplification
Polymerase chain reaction amplification was
carried out in 50 μl reaction mixture containing 
10 μl of DNA, 5 μl of 10 × PCR buffer, 4 μl of MgCl2
(25 mM), 0.5 μl (5 U/μl) of Go Taq Flexi DNA
Polymerase (Promega Cat. No. M8301) [27], 1 μl of
BactF upstream primer (50 pmol/μl), 1 μl of BactR
downstream primer (50 pmol/μl), for Bacteroidetes
detection or 1 μl of FirmF upstream primer 
(50 pmol/μl), and 1 μl of FirmR downstream primer
(50 pmol/μl), for Firmicutes detection, and 4 μl of
dNTPs (10 mM each), and 24.5 μl of DEPC-treated
water. The PCR amplification profile was an initial
denaturation step of 5 min at 95°C followed by 40
cycles of denaturation at 94°C for 45 s, annealing
at 62°C for 45 s (for Bacteroidetes amplification),
while the annealing was 58°C at 45 s (for Firmicutes
amplification), and extension at 72°C for 1.5 min,
with a final extension step of 10 min at 72°C. The
PCR thermal cycling was done using a Biometra PCR
system and the expected PCR product characteristic
for Bacteroidetes was 396 bp and that characteristic
for Firmicutes was 161 bp. 
Gel electrophoresis
The amplified PCR products were electrophore  -
sed through 1.5% agarose gel in Tris acetate/EDTA
(TAE) buffer by using 100 V for 1 h, and the PCR
product bands were visualized by staining with
0.01% ethidium bromide (0.5 μg/ml). Polymerase
chain reaction product bands were visualized under
UV light using a UV transilluminator and photos
were taken using a gel documentation system [28].
Blood samples
Five ml of blood were drawn from the antecubital
vein under aseptic precautions from fasting (for 12-
14 h) subjects. After centrifugation serum was
collected from each subject to evaluate inflam  -
matory markers [hs-CRP, lipid profile (total
cholesterol, HDL cholesterol, LDL cholesterol,
triglyceride)]. 1 – lipid analysis: Lipid assays in sera
were determined by chemistry analyzer Olympus
AU 400. 2 – the serum hs-CRP assay was based on
the chemiluminescence technique. Determination
of hs-CRP concentrations was performed with the
Diagnostic Products Immulite 2000 analyzer (Block
Scientific, Nutley, NJ); assay limits ranged from
below 0.1 mg/l to above 10.0 mg/l.
Statistical analysis
Statistical analysis was performed using the
software SPSS 12.0 (SPSS: Chicago, IL). Variables
were expressed as mean ± standard deviation (SD).
Mean values were compared among subjects using
Student’s t test and ANOVA was used to compare
variables between all groups. For comparing
categorical data, χ2 test was performed. The exact
test was used instead when the expected
frequency was less than 5. Spearman’s correlation
coefficient rho was used to correlate between non-
normally distributed continuous variables. A pro  -
bability value (p value) less than 0.05 was
considered statistically significant.
Results
The results of PCR product bands for Bacteroi  -
detes and Firmicutes by the gel documentation
system of some cases are shown in Figure 1.
Distribution of Bacteroidetes and Firmicutes was
significantly increased in the obese group compared
to the normal weight group (p = 0.003, p < 0.001
respectively) (Table I, II). Only 21 subjects had one
positive bacteria (13 were positive for Firmicutes
and 8 for Bacteroidetes). Table III shows the means
and SDs of different variables and their statistical
significance in both groups. Both cholesterol and
hsCRP were significantly higher in obese individuals
(p = 0.03, p = 0.05 respectively). Table IV shows the
cross-tabulation between Firmicutes and Bactero  -
idetes in children and adults. Firmicutes showed
a statistically significant increase in the adult group
(p = 0.031). As regards the results of dietary
analysis, subjects were divided into low and high
fat intake. According to carbohydrate intake they
were divided into four groups. The fourth group had
the highest carbohydrate intake. We could not
correlate changes in gut microbiota with fat or504 Arch Med Sci 3, June / 2011
Bacteroidetes Total Firmicutes Total
1.00 2.00 1.00 2.oo
Obesity Count 43 9 52 45 7 52
% Within obesity 82.7% 17.3% 100.0% 86.5% 13.5% 100.0%
Normal Count 13 14 27 12 15 27
weight % Within normal 48.1% 51.9% 100.0% 44.4% 55.6% 100.0%
subjects weight
Table I. Distribution of Bacteroidetes and Firmicutes in obese and normal weight subjects
Asymp. sig.  Exact sig.  Exact sig.  Asymp. sig.  Exact sig.  Exact sig. 
(2-sided) (2-sided) (1-sided) (2-sided) (2-sided) (1-sided)
Bacteroidetes Firmicutes 
Pearson χ2 0.001 < 0.001
Continuity correction 0.003 < 0.001
Likelihood ratio 0.002 < 0.001
Fisher's exact test 0.003 0.002 < 0.001 < 0.001
Linear-by-linear  0.001 < 0.001
association
N of valid cases < 0.001 < 0.001
Table II. χ2 Tests for Bacteroidetes and Firmicutes in obese and normal weight subjects      
1000 bp
M C 43 44 45 46 47 48 49
500 bp
Positive
results for
Bacteroidetes
1000 bp
500 bp
Positive
results for
Fimicutes
No growth
1000 bp
M C 64 65 66 67 68 69 70
500 bp
Positive
results for
Bacteroidetes
1 000 bp
500 bp
Positive
results for
Firmicutes
Figure 1. Results of the PCR product bands for Bacteroidetes and Firmicutes by gel documentation system of some
cases
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carbohydrate intake. Interestingly, the study found
a trend for subjects with high fat intake to have
positive Firmicutes, and those with the highest
carbohydrate intake to have positive Bacteroidetes
and Firmicutes (Figure 2). The study also showed
a significant positive trend for higher hsCRP in
subjects with positive Firmicutes (p = 0.004), as
shown in Table V.
Discussion
Obesity is now characterized by a cluster of
several metabolic disorders, and by low grade
inflammation. The evidence that the gut microbiota
composition can be different between healthy and
obese and type 2 diabetic patients has led to the
study of this environmental factor as a key link
between the pathophysiology of metabolic diseases
and the gut microbiota. Techniques based on the
PCR are commonly used and provide rapid
qualitative information on the composition of the
intestinal microbiota [29]. Qualitative changes of
the gut microbiota according to gender and species
are well known and there are wide interpersonal
variations in gut microbiota as a result of host
genetic and environmental factors (e.g. mother’s
microbiota, birth place, diet, and living conditions).
Our study revealed that the proportions of the phyla
Firmicutes and Bacteroidetes were statistically
significantly increased in the obese group compared
to the normal weight group (p < 0.001, p = 0.003
respectively). Results obtained in both rodents and
humans suggest that obesity is associated with an
altered composition of gut microbiota. Turnbaugh
et al. (2009) observed wide shifts of the two major
phyla: obese are characterized by more Firmicutes
versus lean individuals; some authors show a drop
in Bacteroidetes upon obesity [30], whereas other
authors show no change or even an increase of
Bacteroidetes in overweight [30-33]. This highlights
the danger of generalizing observations of changes
in microbiota composition from one population to
another.
To date, 73 genomes of members of Firmicutes
have been fully or partially sequenced. Interestingly,
hydrogen-producing members of the family
Prevotellaceae within the Bacteroidetes phylum, as
well as certain Firmicutes, were more prominent in
microbiota of obese individuals. This is believed to
accelerate fermentation of otherwise indigestible
carbohydrates, thereby leading to increased acetate
production and subsequently higher energy
absorption [34]. A question remains open: are the
changes in gut microbiota in overweight or obese
individuals due to the obesity per se, or due to
changes in nutritional habits in obese people?
To explore the roles of diet on intestinal microbial
ecology, dietary records were analysed for carbo  -
hydrate and fat contents. We could not correlate
changes in gut microbiota with fat or carbohydrate
intake. Interestingly, the study showed a trend for
subjects with high fat intake to have positive
Firmicutes, and those with the highest carbohydrate
intake to have positive Bacteroidetes and
Firmicutes. Other studies have correlated changes
in gut microbiota with carbohydrate intake [35].
Data obtained in animals suggest that a high-fat
diet – and not the obese state per se – can
modulate microbiota com  position towards an
increase in Firmicutes and a proportional decrease
in Bacteroidetes [36]. This highlights the likelihood
Obesity Mean Standard  Sig.
deviation (2-tailed)
FBS 1 93.07 21.82 0.426
2 89.83 11.04 0.419
Cholesterol 1 197.93 37.04 0.038
2 180.91 34.65 0.037
Triglyceride 1 112.31 38.68 0.127
2 96.45 52.97 0.137
HDL 1 41.11 8.16 0.624
2 42.10 9.83 0.629
LDL 1 131.76 37.81 0.143
2 119.72 33.34 0.139
HsCRP 1 6.43 10.31 0.053
2 2.35 3.31 0.036
BMI 1 34.82 5.84 0.000
2 21.85 2.66 0.000
Table III. Comparison between the obese and normal
weight groups
1 – obese group, 2 – normal weight group
FBS  – fasting blood glucose, HDL – high density lipoprotein, LDL – low
density lipoprotein, HsCRP – high-sensitivity C-reactive protein, 
BMI –  body mass index, *p is significant < 0.05
Firmicutes Total Bacteroidetes Total
1 (+ve)2  (–ve)1  (+ve)2  (–ve)
Age group  1 – children Count 22 18 40 27 13 40
% Within age 55.0% 45.0% 100.0% 67.5% 32.5% 100.0%
2 – adults Count 31 8 39 29 10 39
Adult % Within age 79.5% 20.5% 100.0% 74.4% 25.6% 100.0%
Table IV. Firmicutes and Bacteroidetes in children and adults506 Arch Med Sci 3, June / 2011
of external factors such as diet, and potentially host
factors, in modulating the microbiota.
Another point remains to be elucidated: could
we attribute the low grade inflammatory process
observed in obese subjects to changes in the gut
bacteria? Our study showed that hsCRP was
significantly higher in obese individuals (p = 0.05).
The study also showed a significant positive trend
for higher hsCRP in subjects with positive
Firmicutes (p = 0.004). The role of the gut micro  -
biota in modulation of plasma lipopoly  saccharide
(LPS) levels, which triggers the inflammatory tone
and the onset of obesity, might be possible. Cani et
al. (2007) have shown that subcutaneous infusion
of LPS can cause weight gain and insulin resistance
in mice without altering energy intake [37]. In accor  -
dance with this, mice lacking Toll-like receptor 4
(TLR4), which recognizes LPS, are resistant to diet-
induced obesity and insulin resistance [38].
In conclusion, our data support the key idea that
the gut microbiota can contribute to the patho  -
physiology of obesity. This could be considered
when developing strategies to control obesity and
its associated diseases by modifying the gut
microbiota.
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